|
CTTNBP2NL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.998300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.383500E-04 |
| Normal-vs-Stage2 |
6.161400E-01 |
| Normal-vs-Stage3 |
7.783500E-02 |
| Normal-vs-Stage4 |
3.519000E-01 |
| Stage1-vs-Stage2 |
5.710400E-02 |
| Stage1-vs-Stage3 |
2.239400E-01 |
| Stage1-vs-Stage4 |
1.349630E-01 |
| Stage2-vs-Stage3 |
3.533800E-01 |
| Stage2-vs-Stage4 |
7.040400E-01 |
| Stage3-vs-Stage4 |
6.007200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.824350E-03 |
| Normal-vs-AfricanAmerican |
3.208200E-02 |
| Normal-vs-Asian |
7.075600E-02 |
| Caucasian-vs-AfricanAmerican |
3.620600E-01 |
| Caucasian-vs-Asian |
8.371800E-01 |
| AfricanAmerican-vs-Asian |
3.676200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.946200E-02 |
| Normal-vs-Female |
3.015000E-03 |
| Male-vs-Female |
4.726800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.12860000000137E-05 |
| Normal-vs-Age(41-60Yrs) |
5.471700E-02 |
| Normal-vs-Age(61-80Yrs) |
7.175000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.386400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.368250E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.170100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.410000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.512750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.260000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.459000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.624200E-01 |
| Classical-VS-Follicular |
2.95900000057969E-08 |
| Classical-VS-Other |
3.512600E-01 |
| Classical-VS-Normal |
2.46069999999543E-05 |
| Tall-VS-Follicular |
5.001700E-03 |
| Tall-VS-Other |
5.673200E-01 |
| Tall-VS-Normal |
4.433900E-02 |
| Follicular-VS-Other |
3.537000E-01 |
| Follicular-VS-Normal |
1.901780E-01 |
| Other-VS-Normal |
7.383800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.076000E-01 |
| Normal-vs-N1 |
9.162300E-02 |
| N0-vs-N1 |
3.503400E-01 |
|
|
